SCHEMBL8569299

SCHEMBL8569299

O=C(c1ccccc1)c1cc(Cl)ccc1NC(=O)C(Cl)(Cl)Cl

nearest known ligand 0.72

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.67
ALDH1A1 P00352 5/20 0.65
LMNA P02545 3/20 0.65
TP53 P04637 4/20 0.62
GAA P10253 1/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
SERPINE1 P05121 1/20 0.59
POLB P06746 2/20 0.55
MEN1 O00255 1/20 0.55
MAPK1 P28482 1/20 0.55
KMT2A Q03164 1/20 0.55
KDM4E B2RXH2 1/20 0.55
HTT P42858 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6345643 0.86 MAPT (0.64) MAPTALDH1A1LMNATP53GAA
SCHEMBL13440495 0.84 TP53 (0.60) MAPTALDH1A1LMNATP53GAA
SCHEMBL11571840 0.84 MAPT (0.86) MAPTALDH1A1LMNATP53GAA
SCHEMBL27611956 0.84 MAPT (0.72) MAPTALDH1A1LMNATP53GAA
SCHEMBL8569129 0.83 ALDH1A1 (0.62) MAPTALDH1A1LMNATP53GAA
SCHEMBL31344385 0.83 MAPT (0.60) MAPTALDH1A1LMNATP53GAA
SCHEMBL7072156 0.82 MAPT (0.70) MAPTALDH1A1LMNATP53GAA
SCHEMBL11827090 0.82 MAPT (0.72) MAPTALDH1A1LMNATP53GAA
SCHEMBL31000396 0.82 MAPT (0.72) MAPTALDH1A1LMNATP53GAA
SCHEMBL4083067 0.82 NR4A1 (0.53) MAPTALDH1A1LMNATP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0626373-B1 Quinazolinone derivatives SUMITOMO PHARMA (JP) 1998-12-23 EP disclosed
US-5556860-A ANTIISCHEMIC AGENTS, BRAIN DISORDERS AND BLOOD METAL CONCENTRATIONS AND KIDNEY DISEASE SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 1996-09-17 US disclosed
EP-0626373-A1 Quinazolinone derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-30 EP disclosed
US-4099002-A QUINAZOLINONE DERIVATIVES AND A PROCESS FOR PRODUCTION THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1978-07-04 US disclosed
US-3980645-A Fused quinazolinones and a process for production thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1976-09-14 US disclosed